Abstract:Objective: To determine how dysfunctional astrocyte glutamate transporters contribute to microglial pruning of glutamatergic synapses and memory deficiency in Alzheimer’s disease (AD). Background: Astrocytes are the most abundant and heterogeneous type of glial cells in the brain, we tested the hypothesis that amyloid fibrils impair astrocyte glutamate transporters, thus leading to an abnormal accumulation of extrasynaptic glutamate, which in turn contributes to microglial pruning of glutamatergic synapses and memory deficiency in the rodent models of AD. Design/Methods: Aβ1–40 fibrils were microinjected bilaterally into hippocampal CA1 areas in rats. In another cohorts, DL-threo-beta-benzyloxyaspartate (DL-TBOA), a specific inhibitor of glutamate transporter 1 (GLT1), or ceftriaxone (used to enhance GLT1 function) were also microinjected into hippocampal CA1 areas. Immunostaining and immunoblotting were performed to detect the expression of GLT1 in astrocytes. Complement C1q production and microglial pruning of glutamatergic synapses were assessed by 3D immunofluorescence imaging. Morris water maze test was performed to evaluate the cognitive function. Results: A significant GLT1 reduction in the hippocampal astrocytes in rats injected with amyloid fibrils, indicating dysfunctional glutamate uptake. Microinjection of ceftriaxone significantly attenuated C1q expression and endocytosis of vGluT1 within microglia, and improved behavioral performance in the modeled rats. These results suggested that upregulation of GluT1 expression restored the synaptic microglial pruning and cognition impaired by amyloid fibrils. Meanwhile, in naive rats, microinjection of DL-TBOA substantially increased C1q expression, increased localization of vGluT1 within microglia, and impaired performance in the Morris water maze. This suggests that dysfunctional GluT1, which likely leads to extracellular accumulation of glutamate, contributes to C1q-mediated microglial pruning of synapses and cognitive deficits induced by amyloid fibrils. Conclusions: Reduction of astrocytic GLT1 contributes to C1q production and microglial pruning of glutamatergic synapses, hippocampal synaptic dysfunction and memory deficit in the AD model. Disclosure: Dr. Wu has nothing to disclose. Dr. Bie has nothing to disclose. Dr. Naguib has nothing to disclose.

The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

Glutaminase C Regulates Microglial Activation and Pro-inflammatory Exosome Release: Relevance to the Pathogenesis of Alzheimer’s Disease

Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Microglial cGAS deletion protects against amyloid-β induced Alzheimer's disease pathogenesis

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease

The mechanism and consequences of amyloid-β modulating thiamine pyrophosphokinase-1 expression in microglia

Adhesion G protein-coupled receptor ADGRG1 promotes protective microglial response in Alzheimer's disease

Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer's disease

Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis

Transcriptional signature in microglia associated with Aβ plaque phagocytosis

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target

Reduction of Astrocytic Glutamate Transporter Contributes to Amyloid-induced phagocytosis

Integrative Human Genetic and Cellular Analysis of the Pathophysiological Roles of AnxA2 in Alzheimer's Disease

Microglia Mediate the Occurrence and Development of Alzheimer’s Disease Through Ligand-Receptor Axis Communication

Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies

Silencing of long noncoding RNA X-inactive specific transcript alleviates Aβ1-42-induced microglia-mediated neurotoxicity by shifting microglial M1/M2 polarization

Role of Pro-Inflammatory Cytokines Released from Microglia in Alzheimer's Disease.

Spatiotemporal Activation Of The C/Ebp Beta/Delta-Secretase Axis Regulates The Pathogenesis Of Alzheimer'S Disease